CryoCell International Net Worth
CryoCell International Net Worth Breakdown | CCEL |
CryoCell International Net Worth Analysis
CryoCell International's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including CryoCell International's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of CryoCell International's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform CryoCell International's net worth analysis. One common approach is to calculate CryoCell International's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares CryoCell International's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing CryoCell International's net worth. This approach calculates the present value of CryoCell International's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of CryoCell International's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate CryoCell International's net worth. This involves comparing CryoCell International's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into CryoCell International's net worth relative to its peers.
Enterprise Value |
|
To determine if CryoCell International is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding CryoCell International's net worth research are outlined below:
| CryoCell International generated a negative expected return over the last 90 days | |
| CryoCell International has high historical volatility and very poor performance | |
| CryoCell International currently holds 4.45 M in liabilities with Debt to Equity (D/E) ratio of 0.26, which may suggest the company is not taking enough advantage from borrowing. CryoCell International has a current ratio of 0.46, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about CryoCell International's use of debt, we should always consider it together with its cash and equity. | |
| About 48.0% of CryoCell International shares are held by company insiders |
CryoCell International uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in CryoCell International. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CryoCell International's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 30th of November 2023 Next Fiscal Quarter End | View |
Know CryoCell International's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as CryoCell International is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CryoCell International backward and forwards among themselves. CryoCell International's institutional investor refers to the entity that pools money to purchase CryoCell International's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2024-12-31 | 13.6 K | Ubs Group Ag | 2024-12-31 | 3.1 K | Advisor Group Holdings, Inc. | 2024-12-31 | 2 K | Tower Research Capital Llc | 2024-12-31 | 1 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 601 | Sbi Securities Co Ltd | 2024-12-31 | 105 | Northwestern Mutual Wealth Management Co | 2024-12-31 | 100.0 | Bank Of America Corp | 2024-12-31 | 33.0 | Jpmorgan Chase & Co | 2024-12-31 | 11.0 | Hamilton Lane Advisors Llc | 2024-12-31 | 409.7 K | Sfi Advisors, Llc | 2024-12-31 | 165.3 K |
Follow CryoCell International's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 53.18 M.Market Cap |
|
Project CryoCell International's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.07 | 0.08 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | (0.04) | (0.04) |
When accessing CryoCell International's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures CryoCell International's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of CryoCell International's profitability and make more informed investment decisions.
Evaluate CryoCell International's management efficiency
CryoCell International has return on total asset (ROA) of 0.0376 % which means that it generated a profit of $0.0376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 1.292 %, meaning that it created $1.292 on every $100 dollars invested by stockholders. CryoCell International's management efficiency ratios could be used to measure how well CryoCell International manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CryoCell International's Return On Tangible Assets are quite stable compared to the past year. Return On Capital Employed is expected to rise to 0.08 this year, although the value of Return On Equity will most likely fall to (0.04). At this time, CryoCell International's Other Assets are quite stable compared to the past year. Return On Tangible Assets is expected to rise to 0.01 this year, although the value of Net Tangible Assets will most likely fall to (17.6 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (1.87) | (1.78) | |
| Tangible Book Value Per Share | (2.27) | (2.16) | |
| Enterprise Value Over EBITDA | 60.12 | 57.11 | |
| Price Book Value Ratio | (6.13) | (5.83) | |
| Enterprise Value Multiple | 60.12 | 57.11 | |
| Price Fair Value | (6.13) | (5.83) | |
| Enterprise Value | 85.5 M | 81.3 M |
CryoCell International benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue 1.9147 | Revenue | Quarterly Revenue Growth 0.019 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CryoCell International insiders, such as employees or executives, is commonly permitted as long as it does not rely on CryoCell International's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CryoCell International insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CryoCell International Corporate Filings
10K | 28th of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F4 | 23rd of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 27th of December 2024 Other Reports | ViewVerify | |
| 12th of November 2024 Other Reports | ViewVerify |
CryoCell International Earnings per Share Projection vs Actual
CryoCell International Corporate Executives
Elected by the shareholders, the CryoCell International's board of directors comprises two types of representatives: CryoCell International inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CryoCell. The board's role is to monitor CryoCell International's management team and ensure that shareholders' interests are well served. CryoCell International's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CryoCell International's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jill Taymans | CFO and VP of Fin. | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.625 | Dividend Share 0.25 | Earnings Share 0.05 | Revenue Per Share | Quarterly Revenue Growth 0.019 |
The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.